Anti-osteosarcoma trimodal synergistic therapy using NiFe-LDH and MXene nanocomposite for enhanced biocompatibility and efficacy
2023 · Acta Pharmaceutica Sinica B · 17 citations
https://doi.org/10.1016/j.apsb.2023.10.005
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
63
Citations
5
h-index
3
i10-index
Haozhou Shu is an academic researcher from Sichuan University. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Organometallic Complex Synthesis and Catalysis & Advanced Sensor and Energy Harvesting Materials. The author has an h-index of 5, co-authored 6 publications.
https://doi.org/10.1016/j.apsb.2023.10.005
https://doi.org/10.1016/j.polymer.2025.128825
Click to start Chat